FDA Drug Application (020813) for KLONOPIN RAPIDLY DISINTEGRATING by ROCHE

Back to FDA Applications sponsored by ROCHE

Application Number020813
Product Number001
FormTABLET, ORALLY DISINTEGRATING;ORAL
Dosage0.125MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameKLONOPIN RAPIDLY DISINTEGRATING
Active IngredientCLONAZEPAM

Active IngredientCount
List of drugs with Active Ingredient CLONAZEPAM3


Back to FDA Applications sponsored by ROCHE